lx9211
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 7, 2020 (NCT04455633)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Adaptor-associated kinaseINHIBITOR
AAK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06203002 | Phase 2 | Nov 29, 2023 | Lexicon Pharmaceuticals |
| NCT04662281 | Phase 2 | Dec 31, 2020 | Lexicon Pharmaceuticals |
| NCT04455633 | Phase 2 | Jul 7, 2020 | Lexicon Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals | For profit | 3 | 3 | 1 | 2020 |
1 organizations
Page 1 / 1